Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study.

Roshani S, Cohn DM, Stehouwer AC, Wolf H, van der Post JA, Büller HR, Kamphuisen PW, Middeldorp S.

BMJ Open. 2011 Nov 14;1(2):e000257. doi: 10.1136/bmjopen-2011-000257. Print 2011.

PMID:
22102641
[PubMed]
Free PMC Article
2.

The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.

Knol HM, Schultinge L, Veeger NJ, Kluin-Nelemans HC, Erwich JJ, Meijer K.

Thromb Res. 2012 Sep;130(3):334-8. doi: 10.1016/j.thromres.2012.03.007. Epub 2012 Apr 3.

PMID:
22475315
[PubMed - indexed for MEDLINE]
3.

Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?

Roeters van Lennep JE, Meijer E, Klumper FJ, Middeldorp JM, Bloemenkamp KW, Middeldorp S.

J Thromb Haemost. 2011 Mar;9(3):473-80. doi: 10.1111/j.1538-7836.2011.04186.x.

PMID:
21232006
[PubMed - indexed for MEDLINE]
4.

Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.

Kominiarek MA, Angelopoulos SM, Shapiro NL, Studee L, Nutescu EA, Hibbard JU.

J Perinatol. 2007 Jun;27(6):329-34. Epub 2007 Apr 19.

PMID:
17443203
[PubMed - indexed for MEDLINE]
5.
6.

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761.

PMID:
18574280
[PubMed - indexed for MEDLINE]
7.

Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort.

Chauleur C, Cochery-Nouvellon E, Mercier E, Aya G, Marès P, Mismetti P, Lissalde-Lavigne G, Gris JC.

Thromb Haemost. 2008 Nov;100(5):773-9.

PMID:
18989520
[PubMed - indexed for MEDLINE]
8.

Postpartum haemorrhage in Zimbabwe: a risk factor analysis.

Tsu VD.

Br J Obstet Gynaecol. 1993 Apr;100(4):327-33.

PMID:
8494833
[PubMed - indexed for MEDLINE]
9.

Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin.

Andersen AS, Berthelsen JG, Bergholt T.

Acta Obstet Gynecol Scand. 2010;89(1):15-21. doi: 10.3109/00016340903370098.

PMID:
19916891
[PubMed - indexed for MEDLINE]
10.

Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.

Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A.

Thromb Res. 2009 Jul;124(3):262-7. doi: 10.1016/j.thromres.2008.12.005. Epub 2009 Jan 21.

PMID:
19162303
[PubMed - indexed for MEDLINE]
11.

A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.

Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.

Thromb Haemost. 1996 Feb;75(2):246-50.

PMID:
8815569
[PubMed - indexed for MEDLINE]
12.

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.

Creekmore FM, Oderda GM, Pendleton RC, Brixner DI.

Pharmacotherapy. 2006 Oct;26(10):1438-45.

PMID:
16999654
[PubMed - indexed for MEDLINE]
13.

[The course of pregnancy, delivery and puerperium in women with varices and thrombophlebitis of lower extremities, after application of low molecular weight heparins].

Florjański J, Zalewski J, Tomiałowicz M, Heimrath J, Pajak J, Fuchs T, Kłósek A, Klyszcz B.

Ginekol Pol. 2001 Dec;72(12A):1291-5. Polish.

PMID:
11883266
[PubMed - indexed for MEDLINE]
14.

Body mass index and severe postpartum hemorrhage.

Paglia MJ, Grotegut CA, Johnson LN, Thames B, James AH.

Gynecol Obstet Invest. 2012;73(1):70-4. doi: 10.1159/000329335. Epub 2011 Sep 15.

PMID:
21921570
[PubMed - indexed for MEDLINE]
15.

Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.

Lim W, Dentali F, Eikelboom JW, Crowther MA.

Ann Intern Med. 2006 May 2;144(9):673-84.

PMID:
16670137
[PubMed - indexed for MEDLINE]
16.

Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.

Ní Ainle F, Wong A, Appleby N, Byrne B, Regan C, Hassan T, Milner M, Sullivan AO, White B, O'Donnell J.

Blood Coagul Fibrinolysis. 2008 Oct;19(7):689-92. doi: 10.1097/MBC.0b013e32830b14ef.

PMID:
18832911
[PubMed - indexed for MEDLINE]
17.

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Bates SM, Greer IA, Hirsh J, Ginsberg JS.

Chest. 2004 Sep;126(3 Suppl):627S-644S. Review.

PMID:
15383488
[PubMed - indexed for MEDLINE]
18.

A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage.

Lamont RF, Morgan DJ, Logue M, Gordon H.

Prostaglandins Other Lipid Mediat. 2001 Oct;66(3):203-10.

PMID:
11577783
[PubMed - indexed for MEDLINE]
19.

Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.

Romera-Villegas A, Cairols-Castellote MA, Vila-Coll R, Martí-Mestre X, Colomé E, Iguaz I.

Ann Vasc Surg. 2010 Jul;24(5):628-39. doi: 10.1016/j.avsg.2009.08.006. Epub 2009 Nov 25. Review.

PMID:
19932949
[PubMed - indexed for MEDLINE]
20.

Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin.

Lambert JR, Austin SK, Peebles D, Cohen H.

Br J Haematol. 2008 Jul;142(3):453-6. doi: 10.1111/j.1365-2141.2008.07198.x. Epub 2008 May 24.

PMID:
18510687
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk